About Jasmin
Highly accomplished Global Pricing & Market Access expert with significant experience in global product / TA strategy, launch pricing strategy, P&R plans, value proposition development and opportunity assessments.
Deep knowledge of US and EU payer market systems, particularly US MCOs, and interacting directly with payers and other key stakeholders in these markets.
Extensive experience in the oncology, CNS, immunology dermatology and CV spaces, including orphan indications.
Well-versed in championing cross-functional teams, mentoring talent, devising global strategic plans and local implementation strategies to drive results.
My focus is on serving life science & pharmaceutical clients by conducting consulting projects or working as an external consultant within client teams. My work consistently optimizes brand value, directs business development decisions and drives commercial planning as well as clinical development decisions.
German
Native or bilingual
English
Native or bilingual
Remote only
Primarily works remotely
Experience
- Aquilae GmbHConsultantPHARMACEUTICALS INDUSTRYMay 2019 - Today (7 years)Stuttgart, GermanyMy focus is on serving life science & pharmaceutical clients by conducting consulting projects or working as an external consultant within client teams. Specifically, my capabilities include:• Driving projects focused on global commercial as well as pricing, market access and reimbursement strategy for pharmaceutical and biotechnology companies of all sizes and across lifecycle stages• Managing projects / project teams, conducting advanced analysis and developing insights to inform overall product and portfolio strategies as well as M&A and in-licensing / out-licensing decisions• Applying deep knowledge of pricing, market access and reimbursement processes in the US and the EU to drive strategic recommendations• My work consistently optimizes brand value, directs business development decisions and drives commercial planning as well as clinical development decisions• List of example projects available on request
- Windrose Consulting GroupConsultantPHARMACEUTICALS INDUSTRYFebruary 2016 - May 2019 (3 years and 4 months)Philadelphia, United States• Managed over 30 EU-based and global projects focused on pricing & market access strategy for tier one pharmaceutical manufacturers• Developed expert knowledge of US and EU markets and experienced working with payers across HTA markets, including DE, FR, UK and CA• Directed internal teams to adhere to project milestones, collaborated with cross-functional client stakeholders, and delivered client-facing presentations• List of example projects available on request
- Scientific & Market Life Science AdvisingConsultantBIOTECHSeptember 2014 - January 2016 (1 year and 5 months)St. Louis, United States• Managed over 15 consulting projects focused on commercial strategy and pricing & market access for small to mid-sized biotechnology and digital health companies• Delegated project deliverables to analysts and integrated team deliverables to synthesize cohesive reports• Gained deep understanding of US and EU payer systems• Developed analysts and served as point of contact for clients
Reviews
Recommendations
Be the first to recommend Jasmin
Help this freelancer shine by sharing your experience working together.
These freelancer profiles also match your criteria
Agatha Frydrych
Backend Java Software Engineer
4.7
(3)
2
Baptiste Duhen
Fullstack developer
4.6
(4)
5
Amed Hamou
Senior Lead Developer
4
(2)
7
Audrey Champion
Web developer
4.3
(3)
4
Education
- PhDNew York University2015Activities and societies: NYU Consulting Club, Columbia Graduate Consulting Club (CGCC)Activities and societies: NYU Consulting Club, Columbia Graduate Consulting Club (CGCC) Jasmin's research elucidated the similarities and differences in self-renewal and differentiation mechanisms between normal, epithelial stem cells and tumor-propagating cells in squamous cell carcinoma. Her work identified and characterized the role of a cancer-specific transcription factor in tumor-propagating cells in squamous cell carcinoma.
- MasterNew York University2012